Skip to the page

Data / Form D filings / DINYA DNA, Inc.

DINYA DNA, Inc.: Form D filing

DINYA DNA, Inc., a biotechnology company in Oakland, CA, filed a Form D with the SEC in 2026. The latest, on June 22, 2026, reports $3.8 million sold of a $4.3 million offering to 6 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
8000 EDGEWATER DRIVE SUITE 200, Oakland, CA, 94621
Phone
(617) 816-5773
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2024
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
2139809

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Jun 22, 2026New notice$4,297,104$3,772,104$525,0006Jun 18, 2026sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Benjamin LermanExecutive Officer, Director
Eirik Adim MorebExecutive Officer, Director
Andrew FelbingerDirector

Other biotechnology companies in California that filed recently

Every Form D from the week of Jun 22, 2026 · All recent filings in California · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what DINYA DNA, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.